The firm is maintaining its full-year guidance and expects to make the acquisition once Lex Diagnostics obtains 510(k) clearance of its system.

The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.

The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.

Company officials disclosed that it had been eyeing an out from Savanna in the potential acquisition of Lex Diagnostics for at least the past 18 months.

The RiskReveal assay was used to determine which early-stage non-squamous NSCLC patients should undergo adjuvant chemotherapy ...

The partners will work together to explore the use of a technology from Fujirebio subsidiary Fluxus in infectious disease.

The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.

The recommendations, contained in a report to Congress, follow the GAO's inclusion of the HHS on its High-Risk List of government operations due to "persistent deficiencies in [its] ability to perform ...

NEW YORK – Danaher subsidiary Cepheid announced Wednesday that its Xpert HIV-1 Viral Load XC assay has received a medical device license from Health Canada. The next-generation extended coverage test ...

The researchers found that cervical mucus from Pap smears has a higher cell-free DNA yield than plasma in endometrial cancer cases.